tirzepatide weight loss clinical trial for the Maintenance of Body Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity FDA Approves Tirzepatide, A Potential

Resources We Trust Cleveland Clinic: GLP-1 Agonists Brown University Health: Fact and Fictions About Weight Loss Medications I Am Taking a GLP-1 Weight-Loss Medication What Should I Know

Not every researcher will benefit from adding berberine to tirzepatide

Reviews note that energy drinks are often consumed rapidly, in larger volumes, or in combination with other stimulants or alcohol, which can increase total caffeine exposure beyond intended levels

Public knowledge of dehydration and fluid intake practices: variation by participants' characteristics

Phase II Clinical Trials: Efinopegdutide (Merck/Johnson & Johnson/Hanmi Hanma), VK2735 (Viking Therapeutics), BGM0504 (BrightGene), Pemvidutide (Altimmune/Spitfire Pharma), AMG133 (Amgen), Dapiglutide (Zealand Pharma), etc